https://www.selleckchem.com/pr....oducts/valaciclovir-
4 ± 5.1 vs. 12.8 ± 1.4 s, P less then 0.001; PT-INR 1.5 ± 0.5 vs. 1.1 ± 0.1, P less then 0.001; APTT 44.8 ± 26.4 vs. 30.4 ± 4.1 s, P = 0.003). The median National Institutes of Health Stroke Scale (NIHSS) score on admission and the prevalence of large vessel occlusion were significantly lower in the prolongation group (NIHSS 2.0 vs. 9.5, P = 0.007; large vessel occlusion 27% vs. 53%, P = 0.031). The prevalence of large vessel occlusion was low and stroke severity was mild in patients undergoing DOAC therapy with prolongation of
Gefällt mir
Kommentar
Teilen
